These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17451468)

  • 1. Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.
    Reynolds MR; Essebag V; Zimetbaum P; Cohen DJ
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):628-33. PubMed ID: 17451468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA.
    Deitelzweig SB; Lovelace B; Christoph M; Lingohr-Smith M; Lin J; Fermann GJ
    Adv Ther; 2020 Sep; 37(9):3942-3953. PubMed ID: 32699994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany.
    McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B
    Value Health; 2009; 12(2):293-301. PubMed ID: 18657103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland.
    Ciminata G; Geue C; Langhorne P; Wu O
    BMJ Open; 2020 Mar; 10(3):e028575. PubMed ID: 32193256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.
    Coyne KS; Paramore C; Grandy S; Mercader M; Reynolds M; Zimetbaum P
    Value Health; 2006; 9(5):348-56. PubMed ID: 16961553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization.
    Peigh G; Zhou J; Rosemas SC; Roberts AI; Longacre C; Nayak T; Schwab G; Soderlund D; Passman RS
    JACC Clin Electrophysiol; 2024 Apr; 10(4):718-730. PubMed ID: 38430088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN; Jhaveri M; Lin J
    Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study.
    Reynolds MR; Lavelle T; Essebag V; Cohen DJ; Zimetbaum P
    Am Heart J; 2006 Dec; 152(6):1097-103. PubMed ID: 17161061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.
    Walli-Attaei M; Little M; Luengo-Fernandez R; Gray A; Torbica A; Maggioni AP; Bairami F; Huculeci R; Aboyans V; Timmis AD; Vardas P; Leal J
    Europace; 2024 Jun; 26(6):. PubMed ID: 38807488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both.
    Ghushchyan V; Nair KV; Page RL
    Vasc Health Risk Manag; 2015; 11():25-34. PubMed ID: 25565859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
    Ladapo JA; David G; Gunnarsson CL; Hao SC; White SA; March JL; Reynolds MR
    J Cardiovasc Electrophysiol; 2012 Jan; 23(1):1-8. PubMed ID: 21777324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation in Germany: A prospective cost of illness study].
    Spyra A; Daniel D; Thate-Waschke IM; Berghaus S; Willich S; Zeymer U; Rychlik R
    Dtsch Med Wochenschr; 2015 Jul; 140(14):e142-8. PubMed ID: 26182263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
    Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States.
    Kim MH; Johnston SS; Chu BC; Dalal MR; Schulman KL
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):313-20. PubMed ID: 21540439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
    Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Atrial Fibrillation and Costs After Myocardial Infarction: A Community Study.
    Borah BJ; Roger VL; Mills RM; Weston SA; Anderson SS; Chamberlain AM
    Clin Cardiol; 2015 Sep; 38(9):548-54. PubMed ID: 26418757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare resource utilization and direct medical costs associated with index and recurrent
    Feuerstadt P; Stong L; Dahdal DN; Sacks N; Lang K; Nelson WW
    J Med Econ; 2020 Jun; 23(6):603-609. PubMed ID: 31999199
    [No Abstract]   [Full Text] [Related]  

  • 19. Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry.
    Le Heuzey JY; Bassand JP; Berneau JB; Cozzolino P; D'Angiolella L; Doucet B; Mantovani LG; Martelet M; Mouallem J; Muller JJ; Pieper K;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):749-757. PubMed ID: 29861295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Utilization and Costs Reduction after Radiofrequency Ablation For Atrial Fibrillation in the Brazilian Private Healthcare System.
    Saad EB; Tayar DO; Ribeiro RA; Junqueira SM; Andrade P; d'Avila A
    Arq Bras Cardiol; 2019 Jul; 113(2):252-257. PubMed ID: 31365602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.